United States · Series B startup

Who invested in NeuroVasc

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$6.3Mraised across 1 round since 2018, from 1 source

Latest round
Series B, $6.3MMay 2018
Investors
1
See who backed them

The rounds

  1. May 2018
    Series B$6.3M

    Reported by FinSMEsSEC filing: $4.2M sold, first sale Apr 2018

Everyone who backed them

ShangBay CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about NeuroVasc

Who invested in NeuroVasc?

NeuroVasc's investors include ShangBay Capital.

How much has NeuroVasc raised?

NeuroVasc has raised $6.3M across 1 round since 2018.

When did NeuroVasc last raise?

NeuroVasc's most recent round was a Series B of $6.3M in May 2018.

What was NeuroVasc's biggest round?

Its most recent round, $6.3M in May 2018, is also its largest on record.

Who backed NeuroVasc first?

NeuroVasc's first round on record, in May 2018, was backed by ShangBay Capital.

What stage is NeuroVasc at?

NeuroVasc's latest named round is a Series B, in May 2018.

Where is NeuroVasc based?

NeuroVasc is based in the United States.

Companies like NeuroVasc

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.